RESUMO
The pieddecuve (PdC) technique involves using a portion of grape must to undergo spontaneous fermentation, which is then used to inoculate a larger volume of must. This allows for promoting autochthonous yeasts present in the must, which can respect the typicality of the resulting wine. However, the real impact of this practice on the yeast population has not been properly evaluated. In this study, we examined the effects of sulphur dioxide (SO2), temperature, ethanol supplementation, and time on the dynamics and selection of yeasts during spontaneous fermentation to be used as PdC. The experimentation was conducted in a synthetic medium and sterile must using a multi-species yeast consortium and in un-inoculated natural grape must. Saccharomyces cerevisiae dominated both the PdC and fermentations inoculated with commercial wine yeast, displaying similar population growth regardless of the tested conditions. However, using 40 mg/L of SO2 and 1% (v/v) ethanol during spontaneous fermentation of Muscat of Alexandria must allowed the non-Saccharomyces to be dominant during the first stages, regardless of the temperature tested. These findings suggest that it is possible to apply the studied parameters to modulate the yeast population during spontaneous fermentation while confirming the effectiveness of the PdC methodology in controlling alcoholic fermentation.
Assuntos
Etanol , Fermentação , Saccharomyces cerevisiae , Dióxido de Enxofre , Vitis , Vinho , Leveduras , Vitis/microbiologia , Vinho/microbiologia , Vinho/análise , Etanol/metabolismo , Dióxido de Enxofre/farmacologia , Dióxido de Enxofre/metabolismo , Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/crescimento & desenvolvimento , Leveduras/metabolismo , Temperatura , Estresse FisiológicoRESUMO
Objectives: Mast cell (MC) degranulation is a key process in allergic reactions and inflammatory responses. Aspartate aminotransferase 1 (AAT1)-derived endogenous sulfur dioxide (SO2) is an important regulator of MC function. However, the mechanism underlying its role in MC degranulation remains unclear. This study aimed to investigate the mechanism by which endogenous SO2 controlled MC degranulation. Methods: HMC-1 and Rat basophilic leukemia cell MC line (RBL-2H3) were used in the cell experiments. SO2 content was detected by in situ fluorescent probe. MC degranulation represented by the release rate of MC ß-hexosaminidase was determined using a colorimetric assay. Sulfenylation of galectin-9 (Gal-9) in MCs and purified protein was detected using a biotin switch assay. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to determine the exact sulfenylation sites of Gal-9 by SO2. Animal models of passive cutaneous anaphylaxis (PCA) and hypoxia-driven pulmonary vascular remodeling were used to investigate the effect of SO2 on mast cell activation in vivo. Site-directed mutation of Gal-9 was conducted to confirm the exact site of SO2 and support the significance of SO2/Gal-9 signal axis in the regulation of MC degranulation. Results: Degranulation was increased in AAT1-knockdowned MCs, and SO2 supplementation reversed the increase in MC degranulation. Furthermore, deficiency of endogenous SO2 contributed to IgE-mediated degranulation in vitro. Besides, SO2 inhibited IgE-mediated and hypoxia-driven MC degranulation in vivo. Mechanistically, LC-MS/MS analysis and site-directed mutation results showed that SO2 sulfenylated Gal-9 at cysteine 74. Sulfenylation of the 74th cysteine of Gal-9 protein was required in the SO2-inhibited MC degranulation under both physiological and pathophysiological conditions. Conclusion: These findings elucidated that SO2 inhibited MC degranulation via sulfenylating Gal-9 under both physiological and pathophysiological conditions, which might provide a novel treatment approach for MC activation-related diseases.
Assuntos
Degranulação Celular , Cisteína , Galectinas , Mastócitos , Dióxido de Enxofre , Animais , Degranulação Celular/efeitos dos fármacos , Mastócitos/metabolismo , Mastócitos/imunologia , Mastócitos/efeitos dos fármacos , Cisteína/metabolismo , Ratos , Dióxido de Enxofre/farmacologia , Dióxido de Enxofre/metabolismo , Humanos , Galectinas/metabolismo , Camundongos , Masculino , Anafilaxia Cutânea Passiva , Linhagem CelularRESUMO
OBJECTIVE: Cardiomyocyte senescence is an important contributor to cardiovascular diseases and can be induced by stressors including DNA damage, oxidative stress, mitochondrial dysfunction, epigenetic regulation, etc. However, the underlying mechanisms for the development of cardiomyocyte senescence remain largely unknown. Sulfur dioxide (SO2) is produced endogenously by aspartate aminotransferase 2 (AAT2) catalysis and plays an important regulatory role in the development of cardiovascular diseases. The present study aimed to explore the effect of endogenous SO2 on cardiomyocyte senescence and the underlying molecular mechanisms. APPROACH AND RESULTS: We interestingly found a substantial reduction in the expression of AAT2 in the heart of aged mice in comparison to young mice. AAT2-knockdowned cardiomyocytes exhibited reduced SO2 content, elevated expression levels of Tp53, p21Cip/Waf, and p16INk4a, enhanced SA-ß-Gal activity, and elevated level of γ-H2AX foci. Notably, supplementation with a SO2 donor ameliorated the spontaneous senescence phenotype and DNA damage caused by AAT2 deficiency in cardiomyocytes. Mechanistically, AAT2 deficiency suppressed the sulphenylation of signal transducer and activator of transcription 3 (STAT3) facilitated its nuclear translocation and DNA-binding capacity. Conversely, a mutation in the cysteine (Cys) 259 residue of STAT3 blocked SO2-induced STAT3 sulphenylation and subsequently prevented the inhibitory effect of SO2 on STAT3-DNA-binding capacity, DNA damage, and cardiomyocyte senescence. Additionally, cardiomyocyte (cm)-specific AAT2 knockout (AAT2cmKO) mice exhibited a deterioration in cardiac function, cardiomegaly, and cardiac aging, whereas supplementation with SO2 donors mitigated the cardiac aging and remodeling phenotypes in AAT2cmKO mice. CONCLUSION: Downregulation of the endogenous SO2/AAT2 pathway is a crucial pathogenic mechanism underlying cardiomyocyte senescence. Endogenous SO2 modifies STAT3 by sulphenylating Cys259, leading to the inhibition of DNA damage and the protection against cardiomyocyte senescence.
Assuntos
Doenças Cardiovasculares , Cisteína , Camundongos , Animais , Cisteína/metabolismo , Miócitos Cardíacos/metabolismo , Dióxido de Enxofre/farmacologia , Doenças Cardiovasculares/metabolismo , Fator de Transcrição STAT3/metabolismo , Epigênese Genética , DNA/metabolismo , Senescência CelularRESUMO
Recently, gas therapy has emerged as a promising alternative treatment for deep-seated tumors. However, some challenges regarding insufficient or uncontrolled gas generation as well as unclear therapeutic mechanisms restrict its further clinical application. Herein, a well-designed nanoreactor based on intracellular glutathione (GSH)-triggered generation of sulfur dioxide (SO2) gas to augment oxidative stress has been developed for synergistic chemodynamic therapy (CDT)/sonodynamic therapy (SDT)/SO2 gas therapy. The nanoreactor (designed as CCM@FH-DNs) is constructed by employing iron-doped hollow mesoporous silica nanoparticles as carriers, the surface of which was modified with the SO2 prodrug 2,4-dinitrobenzenesulfonyl (DNs) and further coated with cancer cell membranes for homologous targeting. The CCM@FH-DNs can not only serve as a Fenton-like agent for CDT, but also as a sonosensitizer for SDT. Importantly, CCM@FH-DNs can release SO2 for SO2-mediated gas therapy. Both in vitro and in vivo evaluations demonstrate that the CCM@FH-DNs nanoreactor performs well in augmenting oxidative stress for SO2 gas therapy-enhanced CDT/SDT via GSH depletion and glutathione peroxidase-4 enzyme deactivation as well as superoxide dismutase inhibition. Moreover, the doped iron ions ensure that the CCM@FH-DNs nanoreactors enable magnetic resonance imaging-guided therapy. Such a GSH-triggered SO2 gas therapy-enhanced CDT/SDT strategy provides an intelligent paradigm for developing efficient tumor microenvironment-responsive treatments.
Assuntos
Glutationa , Estresse Oxidativo , Dióxido de Enxofre , Estresse Oxidativo/efeitos dos fármacos , Glutationa/metabolismo , Glutationa/química , Dióxido de Enxofre/química , Dióxido de Enxofre/farmacologia , Humanos , Animais , Camundongos , Nanopartículas/química , Terapia por Ultrassom , Camundongos Endogâmicos BALB C , Dióxido de Silício/química , Linhagem Celular Tumoral , FemininoRESUMO
Introducción: Las emisiones de dióxido de azufre (SO2) del volcán Arenal representan un riesgo para la salud ambiental en La Fortuna. Se realizó un análisis teórico de las diferentes variaciones en las concentraciones de SO2 del volcán, con posible impacto a la salud de sus pobladores. Estudios teóricos sobre emisión y dispersión de gases volcánicos, así como su impacto potencial a la salud en el país, han sido realizados en 1999 por Morales & Liao. Material y métodos: Basados en datos de máxima emisión de SO2 del Arenal, se presumen escenarios de diferentes volúmenes de emisión de SO2, a diferentes clases de condiciones atmosféricas. Para determinar el mecanismo de dispersión del SO2 y sus concentraciones en La Fortuna, se utilizó el modelo Gaussiano con cálculo de penacho y dispersión horizontal a nivel de piso. Resultados: Emisiones de SO2 con causales inferiores a 190ton/día no representan riesgo para la salud humana en La Fortuna. Emisiones superiores a 800 ton/día, con velocidades de salida superiores a 40 km/h provocan concentraciones de SO2 cercanas a los 365 ug/m3, (máxima concentración para un período de 24 horas de exposición), para atmósferas tipo A y B. Emisiones de SO2 mayores a 12.000 ton/día, implican un riesgo a la salud de los pobladores de La Fortuna, incluyendo características fatales. Se recomienda implementar monitoreos constantes de las emisiones de SO2 para tomar medidas de protección en La Fortuna en caso de emisiones iguales o mayores a 800 ton/día.